Literature DB >> 3018989

Evaluation of a combined rotavirus and enterotoxigenic Escherichia coli vaccine in cattle.

D R Snodgrass.   

Abstract

A vaccine of rotavirus and K99 antigen from enterotoxigenic Escherichia coli was emulsified in oil adjuvant and administered intramuscularly to pregnant cows. Calves born to and reared on vaccinated dams were protected against experimental rotavirus infection at five days old when compared with calves from unvaccinated control cows. Field trials of the vaccine were carried out in 40 commercial herds, in which half the cows in each herd were selected at random for vaccination and half were left unvaccinated. In 31 herds (2641 cows) there was no significant diarrhoea problem (less than 10 per cent morbidity); these herds were excluded from further analysis. The nine remaining herds did experience a calf diarrhoea problem of greater than 10 per cent morbidity, but on four farms the disease was associated with cryptosporidiosis and on a fifth no enteropathogens were detected; these five farms (461 cows) were also excluded from further analysis. Of the remaining four herds, two beef suckler herds (105 cows) had concurrent rotavirus and cryptosporidial infections, and vaccination was associated with a decreased excretion of rotavirus but not with a decreased incidence of diarrhoea. In the other two dairy herds (68 cows) with prevaccination rotavirus problems, there was a significantly decreased incidence of diarrhoea in calves born to vaccinated cows. No natural field challenge of enterotoxigenic E coli was encountered on any of the trial farms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018989     DOI: 10.1136/vr.119.2.39

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  16 in total

1.  Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals.

Authors:  D R Snodgrass; T A Fitzgerald; I Campbell; G F Browning; F M Scott; Y Hoshino; R C Davies
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 2.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

Review 3.  Viral enteritis in calves.

Authors:  Diego E Gomez; J Scott Weese
Journal:  Can Vet J       Date:  2017-12       Impact factor: 1.008

Review 4.  Potential use of rumen digesta as ruminant diet-a review.

Authors:  Anusorn Cherdthong
Journal:  Trop Anim Health Prod       Date:  2019-07-20       Impact factor: 1.559

5.  Rotavirus serotypes 6 and 10 predominate in cattle.

Authors:  D R Snodgrass; T Fitzgerald; I Campbell; F M Scott; G F Browning; D L Miller; A J Herring; H B Greenberg
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

6.  Serotype 1 and 2 bovine noroviruses are endemic in cattle in the United kingdom and Germany.

Authors:  S L Oliver; E Wood; E Asobayire; D C Wathes; J S Brickell; M Elschner; P Otto; P R Lambden; I N Clarke; J C Bridger
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

7.  Monoclonal anti-idiotype induces antibodies against bovine Q17 rotavirus.

Authors:  E M Cornaglia; Y M Elazhary; B R Brodeur; B G Talbot
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Risk factors for mortality from diarrhea in beef calves in Alberta.

Authors:  F J Schumann; H G Townsend; J M Naylor
Journal:  Can J Vet Res       Date:  1990-06       Impact factor: 1.310

9.  The prevalence of enteric pathogens in diarrhoeic thoroughbred foals in Britain and Ireland.

Authors:  G F Browning; R M Chalmers; D R Snodgrass; R M Batt; C A Hart; S E Ormarod; D Leadon; S J Stoneham; P D Rossdale
Journal:  Equine Vet J       Date:  1991-11       Impact factor: 2.888

10.  Homotypic and heterotypic serum and milk antibody to rotavirus in normal, infected and vaccinated horses.

Authors:  G F Browning; R M Chalmers; C S Sale; T A Fitzgerald; D R Snodgrass
Journal:  Vet Microbiol       Date:  1991-05       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.